| Dr Larry Steve Davidson, MD | |
|
109 Montgomery Dr, Anderson, SC 29621-3333 | |
| (864) 224-5700 | |
| (864) 226-0680 |
| Full Name | Dr Larry Steve Davidson |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 36 Years |
| Location | 109 Montgomery Dr, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154381465 | NPI | - | NPPES |
| P00404250 | Other | RAILROAD MEDICARE | |
| P01616429 | Other | SC | RR MEDICARE |
| 891273N | Medicaid | NC | |
| N00460 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 9400460 (North Carolina) | Secondary |
| 207T00000X | Neurological Surgery | MD16408 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Home Health | Florence, SC | Home health agency |
| Carolina Pines Regional Medical Center | Hartsville, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartsville Medical Group, Llc | 7012062714 | 35 |
News Archive
Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market.
A new stroke preventer from Bayer and Johnson & Johnson – Xarelto moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.
In an innovative, first-in-pediatrics study, available only at Children's Hospital Los Angeles, researchers will be enrolling children between 1 and 18 years of age who have certain types of relapsed or treatment-resistant cancer.
A new analysis shows that individuals with high levels of genetic variation and elevated exposure to ozone in the environment are at an even higher risk for developing autism than would be expected by adding the two risk factors together.
The American Academy of Cosmetic Surgery (AACS) announces the results of its 2007 Procedural Data and since 2002, the average age for patients receiving invasive cosmetic surgery has increased.
› Verified 6 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639102270 PECOS PAC ID: 1951215243 Enrollment ID: O20040130000302 |
News Archive
Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market.
A new stroke preventer from Bayer and Johnson & Johnson – Xarelto moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.
In an innovative, first-in-pediatrics study, available only at Children's Hospital Los Angeles, researchers will be enrolling children between 1 and 18 years of age who have certain types of relapsed or treatment-resistant cancer.
A new analysis shows that individuals with high levels of genetic variation and elevated exposure to ozone in the environment are at an even higher risk for developing autism than would be expected by adding the two risk factors together.
The American Academy of Cosmetic Surgery (AACS) announces the results of its 2007 Procedural Data and since 2002, the average age for patients receiving invasive cosmetic surgery has increased.
› Verified 6 days ago
| Entity Name | Florence Neurosurgery And Spine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306801840 PECOS PAC ID: 5991725897 Enrollment ID: O20051206000584 |
News Archive
Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market.
A new stroke preventer from Bayer and Johnson & Johnson – Xarelto moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.
In an innovative, first-in-pediatrics study, available only at Children's Hospital Los Angeles, researchers will be enrolling children between 1 and 18 years of age who have certain types of relapsed or treatment-resistant cancer.
A new analysis shows that individuals with high levels of genetic variation and elevated exposure to ozone in the environment are at an even higher risk for developing autism than would be expected by adding the two risk factors together.
The American Academy of Cosmetic Surgery (AACS) announces the results of its 2007 Procedural Data and since 2002, the average age for patients receiving invasive cosmetic surgery has increased.
› Verified 6 days ago
| Entity Name | Hartsville Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598995300 PECOS PAC ID: 7012062714 Enrollment ID: O20090902000027 |
News Archive
Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market.
A new stroke preventer from Bayer and Johnson & Johnson – Xarelto moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.
In an innovative, first-in-pediatrics study, available only at Children's Hospital Los Angeles, researchers will be enrolling children between 1 and 18 years of age who have certain types of relapsed or treatment-resistant cancer.
A new analysis shows that individuals with high levels of genetic variation and elevated exposure to ozone in the environment are at an even higher risk for developing autism than would be expected by adding the two risk factors together.
The American Academy of Cosmetic Surgery (AACS) announces the results of its 2007 Procedural Data and since 2002, the average age for patients receiving invasive cosmetic surgery has increased.
› Verified 6 days ago
| Entity Name | Grand Strand Specialty Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821398512 PECOS PAC ID: 0648451344 Enrollment ID: O20110301000770 |
News Archive
Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market.
A new stroke preventer from Bayer and Johnson & Johnson – Xarelto moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.
In an innovative, first-in-pediatrics study, available only at Children's Hospital Los Angeles, researchers will be enrolling children between 1 and 18 years of age who have certain types of relapsed or treatment-resistant cancer.
A new analysis shows that individuals with high levels of genetic variation and elevated exposure to ozone in the environment are at an even higher risk for developing autism than would be expected by adding the two risk factors together.
The American Academy of Cosmetic Surgery (AACS) announces the results of its 2007 Procedural Data and since 2002, the average age for patients receiving invasive cosmetic surgery has increased.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Larry Steve Davidson, MD 109 Montgomery Dr, Anderson, SC 29621-3333 Ph: (864) 224-5700 | Dr Larry Steve Davidson, MD 109 Montgomery Dr, Anderson, SC 29621-3333 Ph: (864) 224-5700 |
News Archive
Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market.
A new stroke preventer from Bayer and Johnson & Johnson – Xarelto moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.
In an innovative, first-in-pediatrics study, available only at Children's Hospital Los Angeles, researchers will be enrolling children between 1 and 18 years of age who have certain types of relapsed or treatment-resistant cancer.
A new analysis shows that individuals with high levels of genetic variation and elevated exposure to ozone in the environment are at an even higher risk for developing autism than would be expected by adding the two risk factors together.
The American Academy of Cosmetic Surgery (AACS) announces the results of its 2007 Procedural Data and since 2002, the average age for patients receiving invasive cosmetic surgery has increased.
› Verified 6 days ago
Dr. Aaron C Macdonald, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 109 Montgomery Dr, Anderson, SC 29621 Phone: 864-512-7190 Fax: 864-226-0680 |